Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.
BACKGROUND:Angiotensin converting enzyme 2 (ACE2) is an endogenous regulator of the renin angiotensin system. Increased circulating ACE2 predicts adverse outcomes in patients with heart failure (HF), but it is unknown if elevated plasma ACE2 activity predicts major adverse cardiovascular events (MAC...
Main Authors: | Jay Ramchand, Sheila K Patel, Piyush M Srivastava, Omar Farouque, Louise M Burrell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5999069?pdf=render |
Similar Items
-
Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock
by: Naomi Pode-Shakked, et al.
Published: (2023-06-01) -
Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
by: Louise M Burrell, et al.
Published: (2017-01-01) -
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
by: Hui Yin Lim, et al.
Published: (2022-09-01) -
Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200) -
Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014-03-01)